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ABSTRACT
Non-steroid anti-inflammatory drugs (NSAID) can cause gastropathy and gastric mucosa, especially the
mucous may play an important prevention role. This cross-sectional, single group study was conducted to
evaluated the difference of mucous thickness in antrum or corpus mucosa and the correlation of gastric
mucous thickness to gastropathy. Patients who received NSAID from the rheumatology clinic were studied.
Healthy subjects of 14 – 65 years old who never received NSAID were included as normal controls. Piroxicam
20 mg daily was given to the patients for 7 days, then gastroscopy and gastric mucosa biopsy with frozen
section were performed. Specimens were stained with haematoxyline eosin and thickness of the mucous layer
was measured using ocular micrometer. Thirty-two out of 70 patients participated in the study. All cases had
hyperemia on gastroscopy with erosions and ulcer in 32 and 9 cases, respectively. The mean thickness of
mucosa in distal antrum, proximal antrum and corpus was 28.5 ± 9, 37.4 ± 13.1 and 43.3 ± 13.1 microns,
respectively. There was significant relationship between gastric mucosa mucous thickness with gastroscopic
findings. In conclusion, this study confirmed that thickness of gastric mucosa mucous has an important role
in  preventing NSAID gastropathy and dyspeptic complaints in this kind of patients does not suggest abnor-
malities of gastric mucosa.
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INTRODUCTION
Non-steroid anti-inflammation drugs (NSAID), es-
pecially salicylie acid are more and more frequently used
in the fields of cardiology and neurology. Several
NSAIDs are sold over the counter and publically used.1
The most commonly reported side effects of NSAID
are those associated with the gastrointestinal system,
especially of the upper gastrointestinal tract. There are
also other side effects on the kidneys, hematopoetic sys-
tem, liver, central nervous system, and skin. The mani-
festation of disturbance in the protective function of the
mucosa can take the form of hyperemia, erosion, ulcer,
bleeding, perforation, and obstruction.1,2,3,4
Based on the study conducted by Manan C in 1986,5
and Rani A and Manan C in 1997,6 at the Division of
Gastroenterology, Department of Internal Medicine, Fac-
ulty of Medicine, University of Indonesia/Cipto
Mangunkusumo Hospital, NSAID users were suffered
from acute mucosa lesion in the form of erosion and
ulcer in the gaster and duodenum in 70-76.6% cases.
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These data suggest a high prevalence of acute mucosa
lesion in NSAID users, even despite the use of protec-
tive agents such as antacids, H2 receptor antagonist,
proton-pump inhibitor, and prostaglandin.6
Gastric mucosa lesions due to NSAID are called
NSAID gastropathy. NSAID gastropathy is an acute
lesion on the mucosa of the upper gastrointestinal tract
due to the use of NSAIDs. The term gastropathy is still
commonly used since the pathologic mechanism in the
formation of such lesions is still unclear, even though
prostaglandin plays the most dominant role.6,7,8,9 One of
the most important factors in the formation of gastropathy
is the defense system of the gastric mucosa. The de-
fense of the gastric mucosa consists of the pre-epithe-
lial, epithelial, and subepithelial layers. The mucous layer
of the gastric mucosa is the initial protective barrier that
is very important in protecting the mucosa from destruc-
tive substances, such as NSAID.2 NSAID could inhibit
mucous production by inhibiting the production of pros-
taglandin, thus causing gastropathy.1,5,7,8,9,10,11
Nissen CH11 reported that misoprostol (an analog of
prostaglandin E1) could increase the thickness of the
gastric mucosa mucous in rats. Clinical studies using
misoprostol in NSAID users reduced gastropathy.11 This
study evaluated gastropathy using gastroscopic exami-
nation, without evaluating mucous thickness. Studies on
the thickness of the gastric mucosa mucous have been
conducted in laboratory animals in order to evaluate the
results of medication using prostaglandin in portal hy-
pertension gastropathy.11,12
NSAID gastropathy has been most commonly re-
ported in the gastric antrum.2,5,13,14,15 There is still no
study report or reference on the thickness of gastric
mucosa mucous in humans that could explain why most
lesions are located at the antrum. Furthermore, there is
still no reference or research that reports a difference in
gastric mucosa mucous thickness at the antrum, corpus,
and fundus in humans, especially in NSAID users. Based
on this data, the author suggests that the gastric mucosa
mucous layer is an important pre-epithelial initial protec-
tive barrier (cytoprotection).
In this study, measurement of gastric mucosa mu-
cous thickness is conducted using biopsy and a modified
method to make the conventional specimen, then the
thickness is measured. The cost of examination is fairly
inexpensive. This is the first time this technique has ever
been used, and it has never been reported in literature.
After a standard technique for measuring mucous thick-
ness is found, the study on the correlation between gas-
tric mucosa mucous thickness and gastroscopic find-
ings in NSAID users is performed.
MATERIALS AND METHOD
Design
The design for this study was single group cross-sec-
tional study.
Time and place
The samples were taken at the Rheumatology out-
patient clinic and room for endoscopic procedure of the
Division of Gastroenterology, Department of Internal
Medicine, Faculty of Medicine, University of Indonesia/
Cipto Mangunkusumo Hospital, from August to December
1998.
Sample
The sample was taken consecutively from new out
patients receiving NSAID of the Rheumatology out-pa-
tient clinic of Cipto Mangunkusumo Hospital, Jakarta.
The cases used are all out patients of the rheumatol-
ogy out patient clinic who are new users of NSAID that
fulfill the criteria for inclusion and exclusion as follows.
Criteria for Inclusion
• All new out patients who have never received
NSAID or have not received NSAID in the last week
• Patients of more than 14 and less then 65 years of age
• Willing to participate in the study
Criteria for Exclusion
• Had suffered from dyspepsia in the previous 3
months and was under therapy using H2 receptor
antagonists or proton pump inhibitors
• History of hematemesis melena due to liver cirrho-
sis and/or portal hypertension
• Took alcohol, drugs (such as corticosteroids) or ate
certain foods (spicy, acidy, etc.) and drank substances
(e.g. Coffee) that could irritate the gaster and cause
dyspepsia in the last week
• Patients with increased body temperature up to
subfebrile or febrile suspected due to pancreatitis,
cholecystitis, cholelithiasis and acute or chronic hepa-
titis
• Patients under medication for the eradication of
Helicobacter pylori or peptic ulcer prior to use of
NSAID in the previous 3 months
• Patients with hypertension, hypotension, acute or
chronic renal failure, diabetes mellitus or gastric
motility disorder
• Patients unwilling to undergo biopsy for histopatho-
logic analysis
• Positive screening for Helycobacter pylori using mi-
cro indol urease (MIU) from specimens of the gas-
tric tissue
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Measurement of mucous thickness of gastric mucosa
Biopsy was taken from the distal antrum of the gaster
(TM 1), proximal antrum/transitional zone and corpus of
the gaster (TM 2) and the corporeal gaster (TM 3). In-
dividual biopsies were taken from the hyperemic region
with what was considered the most severe endoscopic
abnormality, with a radius of approximately 1 cm from
the edges of the erosion or ulcer. Biopsies were taken
from the hyperemic regions since the mucous was still
intact, since in cases with erosion or ulcer, the mucous
layer has been destroyed.2,12,16
The thickness of the mucosa mucous is read using
an ocular micrometer on the light microscope, using 10 x
10 magnification, 1 unit scale on the ocular micrometer
equals 10 microns. If re-measured from 1 scale, mea-
sured using a magnification of 10 x 40, 1 scale equals
2.5 microns,10 according to the criteria for measurement
of mucous thickness used at the Department of Ana-
tomic Pathology of the Faculty of Medicine of the Uni-
versity of Indonesia/Cipto Mangunkusumo Hospital.
The results of gastric mucous thickness were mea-
sured using the area under the curve (AUC) method
with the formula:
AUC = ½ (y0 + 2y1 + 2 y2 + 2 y3 +…..+ 2 y11 + 2
y12 + 2 y13 + y14)
Note: Y0-14 = mucous thickness is read at 15 points
throughout
Method
Each patient that fulfills the requirement would un-
dergo 2 phases of examination, which are as follows:
1. Initial examination, consisting of:
• History taking and filling out questionnaire
• Physical examination, blood laboratory analysis:
hemoglobin, hematocryte, leukocyte, platelet,
blood sugar, ureum, creatinine, ALT, AST, total
billirubin, routine urinalysis and electrocardio-
graphy
2. Advanced examination, consisting of:
• Endoscopic examination of the upper gastrointes-
tinal tract, and gastric biopsy
• Microscopic measurement of the thickness of
the gastric mucosa mucous layer
All patients were given 20 mg of Piroxicam daily for
1 week. Gastroscopy was performed on all patients us-
ing Pentax endoscopic device type EG 3400.
Data processing and analysis
The data collected are processed using a personal
computer. Endoscopic findings and gastric mucous thick-
ness are analyzed using Pearson correlation (bivariate
analysis) using SPSS software (Statistical Package for
Social Sciences) 7.5 for Windows.
RESULTS
From August to December 1998, 70 patients were
selected. There were thirty-seven patients that could fully
participate in the whole study up to endoscopic exami-
nation and examination of gastric mucosa mucous thick-
ness. Samples were taken after a significant correlation
between mucous thickness and gastroscopic findings was
established. The average age was 46.2 years (SD 11.9),
with an age ranging from of 16 to 64 years. There were
14 men (37.8%) and 23 women (62.2%).
SAMPLE CHARACTERISTICS
In this study the gastroscopic abnormalities found
were mostly of severe degree, found in 17 cases (45.9%),
followed by mild degree in 13 cases (35.1%) and others
as seen in the following table.
In this study the site of gastroscopic abnormalities is
mostly located at the antrum, in the form of hyperemia
in all cases (100%), erosion in 32 cases, and ulcer in 9
cases out of the 10 ulcer cases. The 32 patients with
erosion 21 suffered from mild erosion (56.8%), 5 cases
(13.5%) from moderate erosion and 6 cases (16.2%)
from severe erosion.
In this study the most common dyspeptic complaint
was mild dyspepsia in 23 cases (62.2%), followed by 11
cases without complaints (29.7%). Thus, all 34 cases
(91.9%) demonstrated only mild dyspepsia or no dys-
peptic complaints. Out of the 9 cases with ulcer in the
antrum, 5 cases had no complaints of dyspepsia, 4 cases
had mild complaints of dyspepsia. In this study, the com-
plaints of dyspepsia were not related to the degree of
gastroscopic findings.
In this study, the most common complaint for dys-
pepsia is heartburn found in 15 cases, followed by a feel-
ing of gas in the stomach in 14 cases, epigastric discom-
fort in 11 cases, nausea in 10 cases, anorexia in 6 cases
and vomiting in 2 cases.
Table 1. Gastroscopic Findings of the Antrum and Corpus 
Type of lesion Antrum % Corpus % 
Hyperemia 37/37 100 18/37 48.6 
Erosion 32/37 86.5 16/37 43.2 
Ulcer 9/37 24.3 1/37 2.7 
Bleeding 0/37 0 0/37 0 
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The mean thickness of the gastric mucosa mucous
at the distal antrum (TM 1) calculated using the AUC
method was 40 square micrometers (SD 12.9). The cal-
culated mean thickness of gastric mucosa mucous at
the distal antrum (TM 1) was 28.5 micrometers (SD
9.0). The mean thickness of the gastric mucosa mucous
at the proximal antrum (TM 2) calculated using the AUC
method was 52.5 square micrometers (SD 18.4). The
calculated mean thickness of gastric mucosa mucous at
the proximal antrum (TM 2) was 37.4 micrometers (SD
13.1). The mean thickness of the gastric mucosa mu-
cous at the corporeal antrum (TM 3) calculated using
the AUC method was 60.8 square micrometers (SD
18.4). The calculated mean thickness of gastric mucosa
mucous at the corporeal antrum (TM 3) was 43.3 mi-
crometers (SD 13.1).
Table 2. Thickness of gastric mucosa mucous 
Thickness of gastric 
mucosa mucous 
Mean AUC (µm)2 SD (µm)2 Mean AUC (µm) SD (µm) 
Distal antrum (MT 1) 40 12.9 28.5 9.0 
Proximal antrum (MT 2) 52.5 18.4 37.4 13.1 
Corpus (MT 3) 60.8 18.4 43.3 13.1 
Note: AUC= area under the curve, SD=standard deviation, MT=mucous thickness 
Table 3. Correlation Between Gastroscopic Findings and Thickness of Gastric Mucosa at the Distal 
Antrum (Using Pearson Correlation-r) 
Type of abnormality Hyperemia Erosion Ulcer MT 1 
Hyperemia   1.000 0.392** 0.258 0.004 
Erosion  0.392** 1.000 0.167 0.126 
Ulcer   0.258 0.167 1.000 -0.52 
MT 1 0.004 0.126 -0.52 1.000 
Note:  
MT 1 = mucous thickness at the distal antrum 
*       = correlation considered significant at 0.05 (1-tailed) 
**      = correlation considered significant at 0.01 (1-tailed) 
 
Table 4. Correlation Between Gastroscopic Findings and Thickness of Gastric Mucosa at the 
Proximal Antrum (Using Pearson Correlation-r)
 
Type of abnormality Hyperemia Erosion Ulcer MT 2 
Hyperemia   1.000 0.392** 0.258 -0.361* 
Erosion  0.392** 1.000 0.167 -0.161 
Ulcer   0.258 0.167 1.000 -0.82 
MT 2 -0.361* -0.161 -0.82 1.000 
Note:  
MT 2 = mucous thickness at the proximal antrum 
*        = correlation considered significant at 0.05 (1-tailed) 
**      = correlation considered significant at 0.01 (1-tailed)
 
Table 5. Correlation Between Gastroscopic Findings and Thickness of Gastric Mucosa at the 
Corporeal Antrum (Using Pearson Correlation-r) 
Type of abnormality Hyperemia Erosion Ulcer MT 3 
Hyperemia   1.000 0.779** -0.145 -0.404* 
Erosion  0.779** 1.000 -0.119 -0.180 
Ulcer   0.145 -0.119 1.000 -0.21 
MT 3 -0.404** -0.180 -0.21 1.000 
Note:  
MT 3 = mucous thickness at the corporeal antrum 
*        = correlation considered significant at 0.05 (1-tailed) 
**      = correlation considered significant at 0.01 (1-tailed) 
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From the tables above, we can see:
1. There is no significant correlation between gastro-
scopic findings and the thickness of the gastric mu-
cosa mucous at the distal antrum (see Table 3).
2. The analysis reached an r of –0.361, and p = 0.014
with a significant correlation between gastroscopic
findings of hyperemia and TM 2 (thickness of the
proximal antrum mucous) at p <0.05. The analysis
suggest that the thicker the gastric mucosa mucous,
the lower the degree of hyperemia, which was proven
to be a significant correlation for the proximal an-
trum (see Table 4).
3. The analysis reached an r of –0.404, and p = 0.007
with gastroscopic findings of hyperemia and TM 3
(thickness of the corporeal antrum mucous) signifi-
cantly correlated at p <0.05. The analysis suggests
that the thicker the gastric mucosa mucous, the lower
the degree of hyperemia, which was proven to be
significant for the corporeal antrum (see Table 5).
Based on the analysis of gastric mucosa mucous
thickness at the 3 locations of biopsy, only in 2 of the
areas of biopsy, the proximal antrum and corpus. There
was proven a significance for hyperemic gastroscopy
findings. For further analysis on the reliability of this data,
the degree of reliability was evaluated using step-wise
multivariate regression analysis. Based on step-wise
multivariate regression analysis, the following findings
were demonstrated:
The probability for mucosa mucous thinning and the
degree of hyperemia at the proximal antrum was as fol-
lows:
In the probability graph above, p = 0.155 for the nor-
mal mucosa (degree of hyperemia 0). P = 0.514 for mild
hyperemia (degree of hyperemia 1), p = 0.896 for mod-
erate hyperemia (degree of hyperemia 2), and p = 1 for
severe hyperemia (degree of hyperemia 3) correlated
with thinning of the mucosa mucous of the proximal
gaster.
The probability for mucosa mucous thinning and the
degree of hyperemia at the corpus was as follows:
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Figure 1. Graph of the probability of mucosa mucous thinning
              correlated with the degree of hyperemia at the proximal
                 antrum
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0= normal mucosa;
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2= moderate;
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Figure 2. Graph of the probability of mucosa mucous thinning with
         the degree of hyperemia at the corporeal antrum
Note: Degree of hyperemia:
0= normal mucosa;
1= mild; 2= moderate;
3=severe
In the probability graph above, p = 0.525 for the nor-
mal mucosa (degree of hyperemia 0). P = 0.804 for mild
hyperemia (degree of hyperemia 1), p = 0.987 for mod-
erate hyperemia (degree of hyperemia 2), and p = 1 for
severe hyperemia (degree of hyperemia 3) correlated
with thinning of the mucosa mucous of the corporeal
gaster.
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In figure 3, we see the most severe gastroscopic le-
sion in the antrum. In figure 4, we see that the thinnest
gastric mucosa mucous is located at the distal antrum.
DISCUSSION
In this study, the most commonly found gastroscopic
abnormality is found in the antrum, in the form of 100%
hyperemic mucosa, erosion in 32 cases (86.5%) and ul-
cer in 9 out of 10 cases (27%), 7 of them at the pre-
pyloric antrum. Such findings are similar to the results of
studies by Manan,5 Ivey,13 Graham,14 Silvoso,15 Lanza
et al,17 and Eliakim et al,18 using aspirin (regular tablet,
buffer and enteric-coated), naproxen, indomethasine,
piroxicam, and ibuprofen for 1-2 weeks. All of those
researches reported a hyperemic antrum in 76-100%
cases, multiple erosions in the antrum in 40-100% cases,
depending on the dose of medication. The ulcers are
most commonly found in the pre-pyloric antrum (10-31%
cases). Acute gastroscopic lesions are most commonly
found on the first to 14th day.17 Gastroscopic lesions are
most commonly found in the antrum, perhaps due to its
anatomic position as the lowest part of the gaster.8 Oral
medication would directly fall to the antrum and stop for
a while before entering the duodenum. Another possible
cause is that the longest contact between the NSAID
and the gastric mucosa occurs at the antrum.2 A longer
contact time would increase topical irritation, thus caus-
ing further destruction of the mucosa.1,2 There has not
been a study that directly associates the thickness of the
gastric mucosa mucous and the gastroscopic findings in
NSAID users.
This study aimed to determine the correlation between
the thickness of the gastric mucosa mucous and the gas-
troscopic findings at the antrum and corpus. Three bi-
opsy locations were analysed, the distal antrum (TM 1),
the proximal antrum (TM 2), and the corpus (TM 3).
This study found a significant correlation between the
thickness of the mucosa mucous and the gastroscopic
findings of hyperemia at the proximal antrum. The thicker
the mucosa mucous of the proximal antrum (TM 2), the
milder the hyperemia (see Table 4). There was also a
significant correlation between the thickness of the mu-
cosa mucous and the gastroscopic findings of hyperemia
at the corpus, in which the thicker the mucosa mucous
of the corpus (TM 3), the milder the hyperemia (see
Table 5).
 Research on the thickness of gastric mucosa mu-
cous has only been reported in laboratory animals, where
the thickness could be directly measured.11,12 Theoreti-
cally, the mucous layer is the initial barrier of the upper
gastrointestinal tract against foreign objects that enter
the intestinal lumen, protecting the cells under it from
digestion and contact with chemical substances.2 There
have not been any reports on studies on the thickness of
gastric mucosa mucous thickness in NSAID users. In
this study, the most common location of gastroscopic le-
sions is the antrum (100%). The lesions at the corpus
are usually milder, even to the point of remaining normal
(19 cases). On the other hand, the mucous at the antrum
tends to be thinner than that in other parts of the gaster,
in accordance with the degree of the gastroscopic le-
sions observed. This suits the theory of gastric mucosa
histology at the corpus, which has a thicker layer of epi-
thelial cells and more abundant mucous cells (75%) com-
pared to the antrum. Theoretically, the author suggests
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that the mucous layer at the corpus is thicker than that
of the antrum (see Table 2). Thus, the mucous protec-
tion at the corpus is better than that of the antrum,11
which explains why most gastroscopic lesions are lo-
cated at the antrum.
The thickness of the gastric mucosa mucous layer
could act as a protection against various destructive sub-
stances including NSAID, as proven in in vitro studies
on the effects of the prostaglandin E1 analog
(misoprostol) on gastric mucosa protection in rats. In
this study, the thickness of the mucous increased to twice
its original size at the insoluble gel layer (the layer of
mucous that strongly binds to the mucosa) and increased
to three times its original size at the soluble mucous layer
(the dynamic and mobile mucous that acts as a lubri-
cant). The prostaglandin E1 analog was proven to be
able to significantly reduce lesions at the gaster com-
pared to cimetidin and sucralfat.11 Based on the data
above in NSAID users, the author suggests that the
thicker the gastric mucosa mucous layer, the milder the
gastroscopic abnormalities. With a thicker gastric mu-
cosa mucous, there is less contact between the gastric
mucosa epithelium and the NSAID, thus preventing de-
struction of the gastric epithelial cells. Besides the thick-
ness of the mucosa mucous, the quality of the mucous
glycoprotein structure (serine, treonine, proline, and
olygosaccharide chain) also plays a role in keeping it
intact.8,19 Furthermore, many other factors also play a
role, such as prostaglandin, secretin, gastrin, and chole-
cystokinin, which stimulate mucous secretion.7 The in-
fluence of these factors on mucous thickness has not
been subject of research, since it is difficult to deter-
mine. Thus, it is still unclear whether a thicker mucous
would directly correlate with a better quality of gastric
mucosa mucous. As in the study on the analog effects
of prostaglandin E1 on mucous thickness,11 a thicker mu-
cous layer would have a significant correlation in reduc-
ing NSAID gastropathy. Based on this data, the author
suggests that a thicker layer of gastric mucosa mucous
is a manifestation or final product of the complete pre-
epithelial protective function.
Endoscopic findings of erosion or ulcer, and hyper-
emia could not be the basis of establishing the diagnosis
of NSAID gastropathy.5 Histologically, hyperemia is one
of the criteria of NSAID gastropathy,20 while in the case
of erosion and ulcer, histopathologically there is no intact
mucous layer.13,16,17,20 Thus, mucous biopsy is performed
in the most severe hyperemic area at the side of the
lesion. The hyperemic area around the lesion still has an
intact mucosa, including its mucous layer.16 This result
was tested using step-wise multivariate regression analy-
sis. In accordance with testing of the degree of reliabil-
ity against the predicted thinning of the mucosa mucous
layer of the proximal antrum and the corpus, the higher
the degree of hyperemia, the thinner the mucosa mu-
cous layer of the proximal antrum and corpus (see fig-
ures 1 and 2).  Gastroscopically, this study demonstrates
a positive correlation between hyperemia and erosion,
where the higher degree of hyperemia is associated with
more erosion (see table 4, 5 and figure 3). With these
correlation analysis, there is no significant correlation
between the gastroscopic findings and the mucosa mu-
cous thickness at the distal antrum. If analyzed further,
the gastroscopic findings at the distal antrum were more
severe than that of the proximal antrum. In this region,
the motility is higher and the mucous layer thinner than
in the proximal antrum.11 There are fewer mucous cells
that produce mucine at the distal antrum than at the proxi-
mal antrum and corpus, only 20% of mucous cells in the
gaster.8 Similar findings were reported by Silvoso,15 who
mentioned that most gastroscopic lesions, from hyper-
emia to ulcer, are located at the distal antrum. In this
study the mucosa mucous layer of the distal antrum is
most thin compared to other locations (see table 2).
Based on these data the author suggests that a thin layer
of mucosa mucous is one of the main reasons for a more
severe gastroscopic abnormality, (see table 1, figures 3
and 4).
In this study, complaints of dyspepsia were not re-
lated to the severity of gastroscopic findings. Seen from
9 cases of ulcer at the antrum, 5 cases (13.5%) without
complaints, and 4 cases (10.8%) with mild dyspepsia.
This is in accordance with studies by Ivey,13 Graham,14
and Silvoso,15 where ulcers, erosions, and bleeding could
occur without any complaints. Thirty percent of gastric
ulcers occur without any complaints.
CONCLUSION AND SUGGESTIONS
Conclusions
1. There is a significant correlation between the thick-
ness of gastric mucosa mucous and gastroscopic
findings in NSAID users.
2. The thicker the gastric mucosa mucous layer, the
milder the gastroscopic lesion.
3. Gastroscopic lesions are most commonly found in
the antrum.
4. Complaints of dyspepsia in NSAID users do not sig-
nify the presence of gastric mucosa abnormalities
according to gastroscopic examination.
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Suggestions
1. Use of NSAID should be limited to precise indica-
tions, and drugs with the least side effects should be
chosen.
2. Bearing in mind that this was the first time the tech-
nique of gastric mucosa mucous biopsy using frozen
section was used, further studies need to be con-
ducted using a larger number of samples for stan-
dardization of this novel technique.
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